Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants

Expert Opinion on Drug Safety

Volumn 11, Issue 2, 2012, Pages 177-183

  Ehrenpreis, Eli D ^a   Sifuentes, Humberto ^a   Ehrenpreis, Jamie E ^a   Smith, Zachary L ^a   Marshall, Mike L ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Adverse drug reactions; Adverse events reporting system; FDA; Nurse practitioners; Pharmacology; Pharmacovigilence; Physician assistants; Side effects

Indexed keywords

ARTICLE; AWARENESS; COMPARATIVE STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; NURSE PRACTITIONER; PHYSICIAN ASSISTANT; PROFESSIONAL KNOWLEDGE; VOLUNTARY REPORTING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; AWARENESS; DATA COLLECTION; DRUG THERAPY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NURSE PRACTITIONERS; PHARMACOVIGILANCE; PHYSICIAN ASSISTANTS; PROFESSIONAL ROLE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VOLITION;

EID: 84857387094     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2012.650165     Document Type: Article

References (19)

1. FDA U.S. Food and Drug Administration. Adverse Events Reporting System (AERS. Accessed February 15, 2011
2. Bailey S, Singh A, Azadian R, et al. Prospective data mining of six products in the US FDA adverse event reporting system: disposition of events identified and impact on product safety profiles. Drug Saf 2010;33:139-46
3. Hansen RA, Gartlehner G, Powell GE, et al. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007;5:729-35
4. FDA U.S. Food and Drug Administration. FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil. Available from: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm [Accessed 15 February 2011]
5. Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 2010;9:3260-7
6. Gardner G, Gardner A, Middleton S, et al. The work of nurse practitioners. J Adv Nurs 2010;66:2160-9
7. Maehara T, Nishida H, Watanabe T, et al. Surgeons' hope: expanding the professional role of co-medical staff and introducing the nurse practitioner/physician assistant and team approach to the healthcare system. Nippon Geka Gakkai Zasshi 2010;111:209-15
8. Classen DC, Resar R, Griffin F, et al. "Global trigger tool" shows that adverse events in hospital may be ten times greater than previously measured. Health Aff (Millwood) 2011;30:581-9
9. Fukuda H, Imanaka Y, Hirose M, et al. Impact of system-level activities and reporting design on the number of incident reports for patient safety. Qual Saf Health Care 2010;19:122-7
10. Woolsey CV. A Patient's Guide to the Physician Assistant. Available from: http://www.pg2pa.org/PA-NP.html [Accessed 19 November 2011]
11. Bates DW, Cullen DJ. Laird, et al. Incidence of adverse drug events and potential drug events-Implications for prevention. JAMA 1995;274:29-34
12. Kunac DL, Kennedy J, Austin N, et al. Incidence, preventability and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs 2009;11:153-60
13. Kilbridge PM, Noirot LA, Reichley RM, et al. Computerized surveillance for adverse drug events in a pediatric hospital. JAMA 2009;16:607-12
14. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21:541-8
15. McClure DL. Improving drug safety: active surveillance systems should be paramount. Pharm Med 2009;23:127-30
16. Ginsburg L, Norton PG, Casebeer A, et al. An educational intervention to enhance nurse leaders' perceptions of patient safety culture. Health Serv Res 2005;40:997-1020 (Pubitemid 41040658)
17. Gardiner P, Sarma DN, Dog TL, et al. The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2008;17:962-70
18. Hooker RS, Berlin LE. Trends in the supply of physician assistants and nurse practitioners in the United States. Health Aff (Millwood) 2002;21:174-81
19. McCann JL, Phillips RS, O'Neil EH, et al. Physician assistant and nurse practitioner workforce trends. Am Fam Physician 2005;72:1176